EMEA (Europe, Middle East and Africa) Ophthalmic Therapeutic Drugs Market Report 2017

December 2017 | 106 pages | ID: EBF90819CE7EN
QYResearch

Abstracts

In this report, the EMEA Ophthalmic Therapeutic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Ophthalmic Therapeutic Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Ophthalmic Therapeutic Drugs market competition by top manufacturers/players, with Ophthalmic Therapeutic Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bayer
• Pfizer
• Novartis
• ALLERGAN
• Aerie Pharmaceuticals
• Valeant Pharmaceuticals International
• Genentech
• Regeneron Pharmaceuticals
• Shire
• Santen Pharmaceutical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• by Therapeutic Class
• Anti-inflammatory Drugs
• Anti-infective Drugs
• Anti-glaucoma Drugs
• Anti-allergy Drugs
• Anti-VEGF Agents
• Others
• by Product Type
• Prescription Drugs
• Over-the-Counter Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital Pharmacies
• Online Pharmacies
• Independent Pharmacies & Drug Stores

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Ophthalmic Therapeutic Drugs Market Report 2017

1 OPHTHALMIC THERAPEUTIC DRUGS OVERVIEW

1.1 Product Overview and Scope of Ophthalmic Therapeutic Drugs
1.2 Classification of Ophthalmic Therapeutic Drugs
  1.2.1 EMEA Ophthalmic Therapeutic Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Ophthalmic Therapeutic Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Anti-inflammatory Drugs
  1.2.4 Anti-infective Drugs
  1.2.5 Anti-glaucoma Drugs
  1.2.6 Anti-allergy Drugs
  1.2.7 Anti-VEGF Agents
  1.2.8 Others
1.3 EMEA Ophthalmic Therapeutic Drugs Market by Application/End Users
  1.3.1 EMEA Ophthalmic Therapeutic Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital Pharmacies
  1.3.3 Online Pharmacies
  1.3.4 Independent Pharmacies & Drug Stores
1.4 EMEA Ophthalmic Therapeutic Drugs Market by Region
  1.4.1 EMEA Ophthalmic Therapeutic Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Ophthalmic Therapeutic Drugs (2012-2022)
  1.5.1 EMEA Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2022)

2 EMEA OPHTHALMIC THERAPEUTIC DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Ophthalmic Therapeutic Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Ophthalmic Therapeutic Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Ophthalmic Therapeutic Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Ophthalmic Therapeutic Drugs Sale Price by Players (2012-2017)
2.2 EMEA Ophthalmic Therapeutic Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Ophthalmic Therapeutic Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Ophthalmic Therapeutic Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Ophthalmic Therapeutic Drugs Sale Price by Type (2012-2017)
2.3 EMEA Ophthalmic Therapeutic Drugs (Volume) by Application
2.4 EMEA Ophthalmic Therapeutic Drugs (Volume and Value) by Region
  2.4.1 EMEA Ophthalmic Therapeutic Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Ophthalmic Therapeutic Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Ophthalmic Therapeutic Drugs Sales Price by Region (2012-2017)

3 EUROPE OPHTHALMIC THERAPEUTIC DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Ophthalmic Therapeutic Drugs Sales and Value (2012-2017)
  3.1.1 Europe Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Ophthalmic Therapeutic Drugs Sales and Market Share by Type
3.3 Europe Ophthalmic Therapeutic Drugs Sales and Market Share by Application
3.4 Europe Ophthalmic Therapeutic Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Ophthalmic Therapeutic Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Ophthalmic Therapeutic Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST OPHTHALMIC THERAPEUTIC DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Ophthalmic Therapeutic Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Ophthalmic Therapeutic Drugs Sales and Market Share by Type
4.3 Middle East Ophthalmic Therapeutic Drugs Sales and Market Share by Application
4.4 Middle East Ophthalmic Therapeutic Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Ophthalmic Therapeutic Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Ophthalmic Therapeutic Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)

5 AFRICA OPHTHALMIC THERAPEUTIC DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Ophthalmic Therapeutic Drugs Sales and Value (2012-2017)
  5.1.1 Africa Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Ophthalmic Therapeutic Drugs Sales and Market Share by Type
5.3 Africa Ophthalmic Therapeutic Drugs Sales and Market Share by Application
5.4 Africa Ophthalmic Therapeutic Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Ophthalmic Therapeutic Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Ophthalmic Therapeutic Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)

6 EMEA OPHTHALMIC THERAPEUTIC DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Bayer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 ALLERGAN
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Aerie Pharmaceuticals
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Valeant Pharmaceuticals International
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Genentech
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Genentech Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Regeneron Pharmaceuticals
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Shire
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Shire Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Santen Pharmaceutical
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 OPHTHALMIC THERAPEUTIC DRUGS MANUFACTURING COST ANALYSIS

7.1 Ophthalmic Therapeutic Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ophthalmic Therapeutic Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ophthalmic Therapeutic Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA OPHTHALMIC THERAPEUTIC DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Ophthalmic Therapeutic Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Ophthalmic Therapeutic Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Ophthalmic Therapeutic Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Ophthalmic Therapeutic Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Ophthalmic Therapeutic Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Ophthalmic Therapeutic Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Ophthalmic Therapeutic Drugs
Figure EMEA Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Anti-inflammatory Drugs Product Picture
Figure Anti-infective Drugs Product Picture
Figure Anti-glaucoma Drugs Product Picture
Figure Anti-allergy Drugs Product Picture
Figure Anti-VEGF Agents Product Picture
Figure Others Product Picture
Figure EMEA Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Ophthalmic Therapeutic Drugs by Application in 2016
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Independent Pharmacies & Drug Stores Examples
Table Key Downstream Customer in Independent Pharmacies & Drug Stores
Figure EMEA Ophthalmic Therapeutic Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Ophthalmic Therapeutic Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Ophthalmic Therapeutic Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Ophthalmic Therapeutic Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Ophthalmic Therapeutic Drugs Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Ophthalmic Therapeutic Drugs Sales Share by Players (2012-2017)
Figure 2016 Ophthalmic Therapeutic Drugs Sales Share by Players
Figure 2017 Ophthalmic Therapeutic Drugs Sales Share by Players
Figure EMEA Ophthalmic Therapeutic Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Ophthalmic Therapeutic Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Ophthalmic Therapeutic Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Ophthalmic Therapeutic Drugs Revenue Share by Players
Table 2017 EMEA Ophthalmic Therapeutic Drugs Revenue Share by Players
Table EMEA Ophthalmic Therapeutic Drugs Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Ophthalmic Therapeutic Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Ophthalmic Therapeutic Drugs by Type (2012-2017)
Figure EMEA Ophthalmic Therapeutic Drugs Sales Market Share by Type (2012-2017)
Table EMEA Ophthalmic Therapeutic Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Ophthalmic Therapeutic Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Ophthalmic Therapeutic Drugs by Type in 2016
Table EMEA Ophthalmic Therapeutic Drugs Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Ophthalmic Therapeutic Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Ophthalmic Therapeutic Drugs by Application (2012-2017)
Figure EMEA Ophthalmic Therapeutic Drugs Sales Market Share by Application in 2016
Table EMEA Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Ophthalmic Therapeutic Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Ophthalmic Therapeutic Drugs by Region (2012-2017)
Figure EMEA Ophthalmic Therapeutic Drugs Sales Market Share in 2016
Table EMEA Ophthalmic Therapeutic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Ophthalmic Therapeutic Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Ophthalmic Therapeutic Drugs by Region (2012-2017)
Figure EMEA Ophthalmic Therapeutic Drugs Revenue Market Share Regions in 2016
Table EMEA Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017)
Table Europe Ophthalmic Therapeutic Drugs Sales (K Units) by Type (2012-2017)
Table Europe Ophthalmic Therapeutic Drugs Market Share by Type (2012-2017)
Figure Europe Ophthalmic Therapeutic Drugs Market Share by Type in 2016
Table Europe Ophthalmic Therapeutic Drugs Sales (K Units) by Application (2012-2017)
Table Europe Ophthalmic Therapeutic Drugs Market Share by Application (2012-2017)
Figure Europe Ophthalmic Therapeutic Drugs Market Share by Application in 2016
Table Europe Ophthalmic Therapeutic Drugs Sales (K Units) by Countries (2012-2017)
Table Europe Ophthalmic Therapeutic Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Ophthalmic Therapeutic Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Ophthalmic Therapeutic Drugs Sales Market Share by Countries in 2016
Table Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Ophthalmic Therapeutic Drugs Revenue Market Share by Countries in 2016
Figure Germany Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure France Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UK Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Ophthalmic Therapeutic Drugs Sales (K Units) by Type (2012-2017)
Table Middle East Ophthalmic Therapeutic Drugs Market Share by Type (2012-2017)
Figure Middle East Ophthalmic Therapeutic Drugs Market Share by Type (2012-2017)
Table Middle East Ophthalmic Therapeutic Drugs Sales (K Units) by Applications (2012-2017)
Table Middle East Ophthalmic Therapeutic Drugs Market Share by Applications (2012-2017)
Figure Middle East Ophthalmic Therapeutic Drugs Sales Market Share by Application in 2016
Table Middle East Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Ophthalmic Therapeutic Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Ophthalmic Therapeutic Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Ophthalmic Therapeutic Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Ophthalmic Therapeutic Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Ophthalmic Therapeutic Drugs Sales (K Units) by Type (2012-2017)
Table Africa Ophthalmic Therapeutic Drugs Sales Market Share by Type (2012-2017)
Figure Africa Ophthalmic Therapeutic Drugs Sales Market Share by Type (2012-2017)
Figure Africa Ophthalmic Therapeutic Drugs Sales Market Share by Type in 2016
Table Africa Ophthalmic Therapeutic Drugs Sales (K Units) by Application (2012-2017)
Table Africa Ophthalmic Therapeutic Drugs Sales Market Share by Application (2012-2017)
Figure Africa Ophthalmic Therapeutic Drugs Sales Market Share by Application (2012-2017)
Table Africa Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Africa Ophthalmic Therapeutic Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Ophthalmic Therapeutic Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Ophthalmic Therapeutic Drugs Sales Market Share by Countries in 2016
Table Africa Ophthalmic Therapeutic Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Ophthalmic Therapeutic Drugs Revenue Market Share by Countries in 2016
Figure South Africa Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Bayer Ophthalmic Therapeutic Drugs Basic Information List
Table Bayer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Ophthalmic Therapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Bayer Ophthalmic Therapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Ophthalmic Therapeutic Drugs Basic Information List
Table Pfizer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Ophthalmic Therapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Ophthalmic Therapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Novartis Ophthalmic Therapeutic Drugs Basic Information List
Table Novartis Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Ophthalmic Therapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis Ophthalmic Therapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table ALLERGAN Ophthalmic Therapeutic Drugs Basic Information List
Table ALLERGAN Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ALLERGAN Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure ALLERGAN Ophthalmic Therapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure ALLERGAN Ophthalmic Therapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Basic Information List
Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Basic Information List
Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Genentech Ophthalmic Therapeutic Drugs Basic Information List
Table Genentech Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genentech Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Genentech Ophthalmic Therapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Genentech Ophthalmic Therapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Basic Information List
Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Shire Ophthalmic Therapeutic Drugs Basic Information List
Table Shire Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shire Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Shire Ophthalmic Therapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Shire Ophthalmic Therapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Santen Pharmaceutical Ophthalmic Therapeutic Drugs Basic Information List
Table Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Santen Pharmaceutical Ophthalmic Therapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ophthalmic Therapeutic Drugs
Figure Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs
Figure Ophthalmic Therapeutic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Ophthalmic Therapeutic Drugs Major Manufacturers in 2016
Table Major Buyers of Ophthalmic Therapeutic Drugs
Table Distributors/Traders List
Figure EMEA Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Ophthalmic Therapeutic Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Ophthalmic Therapeutic Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Ophthalmic Therapeutic Drugs Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Ophthalmic Therapeutic Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Ophthalmic Therapeutic Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Ophthalmic Therapeutic Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Ophthalmic Therapeutic Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Ophthalmic Therapeutic Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Ophthalmic Therapeutic Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Ophthalmic Therapeutic Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Ophthalmic Therapeutic Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources